Today, Ranking Member Raul Ruiz (CA-25) and Representatives Deborah Ross (NC-02), Jamie Raskin (MD-08), Debbie Dingell (MI-12), Ami Bera (CA-06), Kweisi Mfume (MD-07), Robert Garcia (CA-42), and Jill Tokuda (HI-02), formers Members of the Select Subcommittee on the Coronavirus Pandemic, released the following statement:

“As former ranking member, and members of the Select Subcommittee on the Coronavirus Pandemic, we express our deep concern over the Food and Drug Administration's (FDA) recent decision to limit the approval of updated COVID-19 vaccines primarily to older adults and individuals with underlying health conditions.

“We find it perplexing that this new guidance undermines the foundational principles of Operation Warp Speed, a program initiated under the Trump administration, which successfully accelerated the development and distribution of COVID-19 vaccines, saving millions of lives. The current policy appears to disregard the proven benefits of widespread vaccination and may hinder our nation's ability to respond effectively to future COVID-19 variants.

“Furthermore, the decision to require extensive clinical trials for low-risk populations could delay the availability of updated vaccines, potentially leaving millions without timely access to necessary protection.

“We urge the FDA to reconsider this policy change and to prioritize a science-based approach that ensures equitable access to COVID-19 vaccines for all Americans, regardless of age or health status. Maintaining robust vaccination efforts is essential to safeguarding public health and preventing future outbreaks.

“We stand ready to work with the FDA and other stakeholders to uphold the integrity of our nation's public health initiatives and to ensure that the lessons learned from Operation Warp Speed continue to guide our response to the ongoing pandemic.”